Medium materiality6/10
Integra LifeSciences price target lowered to $15 from $18 at Wells Fargo
Why it may matterVerify against the original reporting
target_downscaled
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo lowers Integra LifeSciences target to $15 from $18; current price $12.68.
- Target lowered to $15 from $18; price $12.68.
Key facts
- 01
Target: $15
- 02
Posted price: $12.68
- 03
Analyst firm: Wells Fargo
- 04
Analyst: Larry Biegelsen
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.